Skip to content

Public FDA record

Z-1303-04: Roche brand Reflotron GPT (ALT) 30 test strips; catalog # 745138.

Recall record Z-1303-04 for Roche Diagnostics Corp.. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-1303-04
Company in FDA record
Roche Diagnostics Corp.
FDA classification date
Jul 31, 2004
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 20, 2026
Recall classification
Unknown — no matched enforcement classification

Reason stated in the source

Coating defect may result is falsely decreased patient and/or control results.

Source facts

Action
Recall letters dated 7/14/04 were sent to each customer asking that use of these lots be stopped immediately. Testing labs were asked to notify the attending physician for any patients tested with these test strips.
Initiated
2004-07-14
Root cause
Other
Terminated
2004-10-14
Distribution
United States.
Recall number
Z-1303-04
Recall status
Terminated
CDRH record ID
34088
FDA classified
2004-07-31
Recall event number
29550

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗